NM_001093.4:c.-10+2501A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001093.4(ACACB):​c.-10+2501A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.555 in 151,980 control chromosomes in the GnomAD database, including 24,927 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.55 ( 24927 hom., cov: 32)

Consequence

ACACB
NM_001093.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.449

Publications

4 publications found
Variant links:
Genes affected
ACACB (HGNC:85): (acetyl-CoA carboxylase beta) Acetyl-CoA carboxylase (ACC) is a complex multifunctional enzyme system. ACC is a biotin-containing enzyme which catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, the rate-limiting step in fatty acid synthesis. ACC-beta is thought to control fatty acid oxidation by means of the ability of malonyl-CoA to inhibit carnitine-palmitoyl-CoA transferase I, the rate-limiting step in fatty acid uptake and oxidation by mitochondria. ACC-beta may be involved in the regulation of fatty acid oxidation, rather than fatty acid biosynthesis. [provided by RefSeq, Oct 2022]
UNG (HGNC:12572): (uracil DNA glycosylase) This gene encodes one of several uracil-DNA glycosylases. One important function of uracil-DNA glycosylases is to prevent mutagenesis by eliminating uracil from DNA molecules by cleaving the N-glycosylic bond and initiating the base-excision repair (BER) pathway. Uracil bases occur from cytosine deamination or misincorporation of dUMP residues. Alternative promoter usage and splicing of this gene leads to two different isoforms: the mitochondrial UNG1 and the nuclear UNG2. The UNG2 term was used as a previous symbol for the CCNO gene (GeneID 10309), which has been confused with this gene, in the literature and some databases. [provided by RefSeq, Nov 2010]
UNG Gene-Disease associations (from GenCC):
  • hyper-IgM syndrome type 5
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.74 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001093.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACACB
NM_001093.4
MANE Select
c.-10+2501A>G
intron
N/ANP_001084.3O00763-1
ACACB
NM_001412734.1
c.-10+5790A>G
intron
N/ANP_001399663.1O00763-1
ACACB
NM_001412737.1
c.26+5790A>G
intron
N/ANP_001399666.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACACB
ENST00000338432.12
TSL:1 MANE Select
c.-10+2501A>G
intron
N/AENSP00000341044.7O00763-1
UNG
ENST00000699563.1
c.775-6740A>G
intron
N/AENSP00000514437.1A0A8V8TNE1
ENSG00000256139
ENST00000541704.2
TSL:5
n.576+5790A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.555
AC:
84211
AN:
151862
Hom.:
24883
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.747
Gnomad AMI
AF:
0.327
Gnomad AMR
AF:
0.609
Gnomad ASJ
AF:
0.464
Gnomad EAS
AF:
0.724
Gnomad SAS
AF:
0.506
Gnomad FIN
AF:
0.509
Gnomad MID
AF:
0.389
Gnomad NFE
AF:
0.432
Gnomad OTH
AF:
0.535
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.555
AC:
84310
AN:
151980
Hom.:
24927
Cov.:
32
AF XY:
0.558
AC XY:
41428
AN XY:
74246
show subpopulations
African (AFR)
AF:
0.747
AC:
30994
AN:
41484
American (AMR)
AF:
0.609
AC:
9305
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.464
AC:
1609
AN:
3468
East Asian (EAS)
AF:
0.724
AC:
3725
AN:
5148
South Asian (SAS)
AF:
0.505
AC:
2430
AN:
4812
European-Finnish (FIN)
AF:
0.509
AC:
5367
AN:
10548
Middle Eastern (MID)
AF:
0.391
AC:
115
AN:
294
European-Non Finnish (NFE)
AF:
0.432
AC:
29337
AN:
67936
Other (OTH)
AF:
0.537
AC:
1130
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1786
3573
5359
7146
8932
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
714
1428
2142
2856
3570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.534
Hom.:
3289
Bravo
AF:
0.569
Asia WGS
AF:
0.629
AC:
2186
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.6
DANN
Benign
0.49
PhyloP100
-0.45
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs246084; hg19: chr12-109557010; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.